COCHLEAR LIMITED
-
Open
209.55
-
Previous Close
209.50
-
Volume (Avg)
124.74k (92.45k)
-
Day's Range
209.55-213.88
-
52Wk Range
178.55-236.43
-
Market Cap.
13.78B
-
Dividend Rate (Yield)
2.54 (1.41%)
-
Beta
-
-
Shares Outstanding
-
-
P/E Ratio (EPS)
48.38 (-)
Top Stories
-
Accused Kennewick murderer doesn't believe wife is dead. Will he be able to stand trial?
Tri-City Herald 11/20/2022Nov. 19—A 73-year-old Kennewick man isn't mentally healthy enough to stand trial for his wife's murder, and it's uncertain if he can be treated. While it's clear from an Eastern State Hospital report that Leroy N. Martin isn't currently able to help his attorney, it's less clear how much treatment will be able to help. Martin faces one count of second-degree murder after he allegedly attacked ...
-
Tetanus Explained: Causes, Symptoms, And Treatments
Health Digest -
Woo Pig Su’a for Bentonville lineman
Scorebook Live -
2014 Highlights: 7 Brave Hero Dogs Who Saved the Day
Great Pet Care -
Moving moment boy sees a person on TV who’s deaf like him
talker 11/21/2022“He was excited to see a little boy on his favorite show that had a hearing device just like him." The post Moving moment boy sees a person on TV who’s deaf like him appeared first on Talker.
-
Over a billion young people may be at risk of hearing loss from headphones and loud venues
EL PAÍS -
Adult Cochlear Implant: Carol's Story
Johns Hopkins Medicine -
Cochlear Implant Market New Report by Global Industry Analysis - Share & New Technological Trends till 2027
MarketWatch -
Binaural Cochlear Implant Market Size in 2023 ( New Report ) Drive Growth & Key Performance Indicator is set clearly till 2028
MarketWatch -
Cochlear Implants
Baylor College of Medicine -
The Gift of Hearing: The Huegel Family Story
Johns Hopkins Medicine -
What to Expect during Cochlear Implant Surgery
UUHC Health Feed -
Cochlear Implant: 3 Types of Hearing Loss This Solution May Treat
WebMD -
Envoy Medical Early Feasibility Study of Breakthrough Fully Implanted Cochlear Implant Now Underway
newsroom.businesswire.com -
FDA approves Cochlear's Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology
Business Insider 11/1/2022The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology LONE TREE, Colo., Nov. 1, 2022 /PRNewswire/ -- Cochlear Limited (ASX ...
-
Cochlear wins FDA approval for ear implant
Seeking Alpha -
Cochlear: Result 2022
Intelligent Investor -
Cochlear share price in focus as sales revenue surges to record $1.6b
Motley Fool Australia
